Morristown, NJ, and Mumbai, India—A small new human trial suggests that Curcuwin Ultra+, a new ingredient from OmniActive Health Technologies, is more bioavailable than the standard 95% curcumin extract. Specifically, the study—published in Advances in Therapy—found that 250mg Curcuwin Ultra+ was 144x more bioavailable than standard curcumin. A press release...
East Windsor, NJ—Sabinsa has obtained Novel Food approval from the European Food Safety Authority (EFSA) for its patented Curcumin C3 Reduct, which contains the curcuminoid metabolites Tetrahydrocurcuminoids (THCs). Once a novel food is authorized and added to the list, it may be sold throughout the EU, the press release says.
Landing, NJ—Curcugen from Dolcas Biotech may have applications in reducing analgesic use in those with osteoarthritis, according to a new study published in Nutrients. The randomized, double-blind, placebo-controlled study was conducted on 101 participants aged 45 to 70 years old, who had suffered knee pain for 3 or more months,...
OmniActive Health Technologies has added Curcuwin Ultra+ to its curcumin portfolio. Curcuwin Ultra+ is a clinically studied, natural solution to help support joint and general health benefits for on-the-go lifestyles by delivering: 1) efficacy at a low dose; 2) formulation flexibility and an excellent organoleptic profile allowing for incorporation into...
Spring, TX—The Global Curcumin Association (GCA) has announced the publication in Food Chemistry of a study considering analytical strategies to determine the labeling accuracy and adulteration of turmeric supplements. “Our recent GCA testing, confirmed by others, has determined that some products on the market are adulterated or lack adequate levels...
Kerala, India—A new study has found that a branded turmeric extract could potentially help lessen damage from Alzheimer’s disease on organs other than the brain, according to a press release from Arjuna Natural Pvt, makers of Curcugreen/BCM-95 turmeric extract. Alzheimer’s disease is marked by progressive deficit in memory and cognitive...
Mumbai, India—Nutriventia, a brand from Inventia Healthcare, has announced a new study on its branded turmeric ingredient TurmXTRA 60N, published in Clinical Pharmacology: Advances and Applications. The 90-day, randomized, double-blind, placebo-controlled, clinical trial was conducted in 96 healthy adults who experienced chronic knee pain following physical exertion. The findings: The...
Bloomingdale, IL—NOW Foods has tested curcumin/turmeric extract products sold on Amazon, and has identified issues with potency, heavy metals, mislabeling, and adulteration, according to a press release. NOW tested 23 unknown brand product samples and two NOW products, all purchased from Amazon in June 2021. With regards to potency, the...
East Windsor, NJ—Sabinsa’s Curcumin C3 Complex with BioPerine was used as adjuvant therapy for COVID-19 in a double-blind, randomized, controlled clinical trial conducted on COVID-19 patients in India, according to a press release. The trial involved a total of 140 patients with mild, moderate, and severe symptoms of COVID-19. Patients...
A study published in The Journal of Nutrition has found that TurmiPure Gold, a branded curcumin extract from Naturex, is bioavailable at a low dose. The randomized, cross-over pharmacokinetic study was performed on 30 healthy adults, and included what the press release calls “the most exhaustive quantification of curcuminoids metabolites...
